Flexion Therapeutics Inc (FLXN) Inventory Turnover Ratio, from third quarter 2021 to third quarter 2020, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Flexion Therapeutics Inc   (NASDAQ: FLXN)
 

Flexion Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2021, Flexion Therapeutics Inc 's inventory turnover ratio sequentially decreased to 1.54 in the third quarter 2021, otherwise the ratio remained above the average, as FLXN's markets remain strong.Flexion Therapeutics Inc 's average inventory processing period in the Sep 30 2021 quarter, has increased to 237 days, from 235 days, in the Jun 30 2021 quarter.

Within Healthcare sector 294 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2021, to 1772, from total ranking in the second quarter 2021 at 1774.

FLXN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Flexion Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FLXN Inventory Turnover Ratio (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Inventory Growth -18.29 % -36.57 % -36.59 % -6.87 % 21.53 %
Y / Y Cost of Sales Growth -27.35 % -9.16 % 167.36 % 61.97 % 78.62 %
Inventory Turnover Ratio (TTM) 1.54 1.55 1.41 1.06 0.91
FLXN's Total Ranking # 1772 # 1774 # 1796 # 1859 # 1771
Average inventory processing period 237 236 259 345 401
Seq. Inventory Growth 19.25 % -2.96 % -17.66 % -14.25 % -7.42 %
Seq. Cost of Sales Growth -25.15 % -18.18 % -4.35 % 24.02 % -6.4 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 88
Healthcare Sector # 295
Overall Market # 1772

Inventory Turnover Ratio Statistics
High Average Low
1.65 1.1 0.65
(Sep 30 2018)   (Mar 31 2020)



FLXN Company Profile >> Back to FLXN Efficiency Comparisons >> Compare FLXN Inventory Turnover Ratio to its Competitors

Financial Statements
Flexion Therapeutics Inc 's Inventories $ 15 Millions Visit FLXN's Balance sheet
Flexion Therapeutics Inc 's Cost of Revenues TTM $ 21 Millions Visit FLXN's Income Statement
What are FLXN's Sales? Visit FLXN's Sales by Segment

Other Inventory Turnover Ratios
Flexion Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
FLXN's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for FLXN's Competitors
Inventory Turnover Ratio for FLXN's Suppliers
Inventory Turnover Ratio for FLXN's Customers

You may also want to know
FLXN's Sales Growth Rates FLXN's Pe Price to earnings ratio FLXN's Receivables Turnover Ratio FLXN's Stock Quote
FLXN's Net Income Growth Rates FLXN's Ps Price to Sales ratio FLXN's Sales per Employee FLXN's Asset Turnover Ratio
FLXN's Net Margin FLXN's Pb Price to Book ratio FLXN's Financial Strength Ratios FLXN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2021 Inventories at quarter ending Sep 30 2021
Nabriva Therapeutics Plc  3.96 $ 8.247  Millions$ 2  Millions
Caredx Inc   3.92 $ 56.371  Millions$ 14  Millions
Eagle Pharmaceuticals inc   3.89 $ 31.678  Millions$ 8  Millions
Iridex Corp  3.87 $ 28.542  Millions$ 7  Millions
Teva Pharmaceutical Industries Limited  3.86 $ 8,640.000  Millions$ 2,236  Millions
Prestige Consumer Healthcare Inc   3.86 $ 429.288  Millions$ 111  Millions
Becton Dickinson And Company  3.79 $ 10,741.000  Millions$ 2,832  Millions
Endo International Plc  3.79 $ 1,279.380  Millions$ 338  Millions
American Bio Medica Corporation  3.78 $ 1.829  Millions$ 0  Millions
Baxter International Inc   3.77 $ 7,561.000  Millions$ 2,006  Millions
Electromed Inc   3.75 $ 8.895  Millions$ 2  Millions
Akebia Therapeutics Inc   3.75 $ 166.279  Millions$ 44  Millions
Organogenesis Holdings Inc   3.72 $ 107.122  Millions$ 29  Millions
Mallinckrodt Plc  3.72 $ 1,330.700  Millions$ 358  Millions
Mannkind Corporation  3.69 $ 23.043  Millions$ 6  Millions
Agilent Technologies inc   3.69 $ 2,912.000  Millions$ 790  Millions
Urogen Pharma Ltd   3.64 $ 4.220  Millions$ 1  Millions
Fortress Biotech Inc   3.62 $ 26.840  Millions$ 7  Millions
Precision Optics Corporation Inc   3.62 $ 7.156  Millions$ 2  Millions
Bausch Health Companies Inc   3.62 $ 2,379.000  Millions$ 658  Millions
Icad Inc  3.60 $ 10.610  Millions$ 3  Millions
Universal Biosensors Inc   3.54 $ 6.285  Millions$ 2  Millions
Horizon Therapeutics Public Limited Company  3.53 $ 715.292  Millions$ 202  Millions
Heska Corporation  3.51 $ 145.433  Millions$ 41  Millions
Illumina Inc   3.46 $ 1,314.000  Millions$ 379  Millions
Abbott Laboratories  3.46 $ 18,264.000  Millions$ 5,275  Millions
Histogen Inc   3.45 $ 0.416  Millions$ 0  Millions
Ocular Therapeutix Inc   3.42 $ 3.978  Millions$ 1  Millions
Lannett Company Inc  3.41 $ 390.252  Millions$ 114  Millions
Mettler toledo International Inc   3.36 $ 1,135.629  Millions$ 338  Millions

Date modified: 2026-09-08T15:10:25+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.